Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
ObjectiveTo assess the safety profile of oral Janus kinase (JAK) inhibitors for treating alopecia areata (AA) among adults.MethodsA comprehensive search was conducted up to July 2025 across PubMed, Cochrane Library, Embase, and Web of Science for randomized controlled trials (RCTs) on oral JAK inhib...
Saved in:
| Main Authors: | Ziyu Qi, Yan Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1576553/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modern Management Approaches for Alopecia Areata
by: Eduard T. Ambarchyan, et al.
Published: (2024-12-01) -
Strategies for Managing Suboptimal Response to JAK Inhibitors in Alopecia Areata
by: S. Morteza Seyed Jafari, et al.
Published: (2025-08-01) -
Jak inhibitors in the treatment of alopecia areata - a literature review
by: Paulina Krzeszowska, et al.
Published: (2025-06-01) -
Janus kinase inhibitors for alopecia areata: a review of clinical data
by: Yutong Sun, et al.
Published: (2025-05-01) -
Therapeutic Burden as Predictor of Response to Baricitinib for Alopecia Areata in Real Life: Prospective Study
by: Daniel Muñoz-Barba, et al.
Published: (2025-07-01)